Literature DB >> 16620772

A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers.

Tianwei Li1, Rasa Santockyte, Rong-Fong Shen, Ephrem Tekle, Guanghui Wang, David C H Yang, P Boon Chock.   

Abstract

Ubiquitin-like modifiers (UBLs) contain ubiquitin homology domains and can covalently modify target proteins in a manner similar to ubiquitylation. In this study, we revealed a general proteomic approach to elucidate the enzymatic pathways and identify target proteins for three UBLs: SUMO-2, SUMO-3, and NEDD8. Expression plasmids containing the cDNAs of Myc/6xHis doubly-tagged processed or non-conjugatable forms of these UBLs were constructed. The constructed vectors were then used to transfect HEK 293 Tet-On cells, and stable cell lines expressing these UBLs and their mutants were established. The epitope-tagged proteins were purified by immunoprecipitation under native conditions or by affinity chromatography on nickel resin under denaturing conditions. Purified proteins were analyzed using liquid chromatography coupled with mass spectrometry (LC-MS/MS). Most of the E1-like activating enzymes, E2-like conjugating enzymes and the majorities of the known target as well as some previously unreported proteins for SUMO-2, SUMO-3, and NEDD8 pathways were identified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16620772     DOI: 10.1016/j.abb.2006.03.002

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

Review 1.  Dissecting the ubiquitin pathway by mass spectrometry.

Authors:  Ping Xu; Junmin Peng
Journal:  Biochim Biophys Acta       Date:  2006-09-14

2.  Ribosomal proteins are targets for the NEDD8 pathway.

Authors:  Dimitris P Xirodimas; Anders Sundqvist; Akihiro Nakamura; Linnan Shen; Catherine Botting; Ronald T Hay
Journal:  EMBO Rep       Date:  2008-02-15       Impact factor: 8.807

Review 3.  Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series.

Authors:  Gwénaël Rabut; Matthias Peter
Journal:  EMBO Rep       Date:  2008-09-19       Impact factor: 8.807

Review 4.  Regulation of T cell receptor complex-mediated signaling by ubiquitin and ubiquitin-like modifications.

Authors:  Samantha F Friend; Francina Deason-Towne; Lisa K Peterson; Allison J Berger; Leonard L Dragone
Journal:  Am J Clin Exp Immunol       Date:  2014-12-05

5.  The Protein Neddylation Pathway in Trypanosoma brucei: FUNCTIONAL CHARACTERIZATION AND SUBSTRATE IDENTIFICATION.

Authors:  Shanhui Liao; Huiqing Hu; Tao Wang; Xiaoming Tu; Ziyin Li
Journal:  J Biol Chem       Date:  2016-12-12       Impact factor: 5.157

6.  FAT10 modifies p53 and upregulates its transcriptional activity.

Authors:  Tianwei Li; Rasa Santockyte; Shiqin Yu; Rong-Fong Shen; Ephrem Tekle; Caroline G L Lee; David C H Yang; P Boon Chock
Journal:  Arch Biochem Biophys       Date:  2011-03-09       Impact factor: 4.013

Review 7.  Ubiquitin proteolytic system: focus on SUMO.

Authors:  Van G Wilson; Phillip R Heaton
Journal:  Expert Rev Proteomics       Date:  2008-02       Impact factor: 3.940

8.  Development and validation of a method for profiling post-translational modification activities using protein microarrays.

Authors:  Sonia V Del Rincón; Jeff Rogers; Martin Widschwendter; Dahui Sun; Hans B Sieburg; Charles Spruck
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

9.  A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins.

Authors:  Jeffrey Jones; Kenneth Wu; Yingying Yang; Cortnie Guerrero; Nadinath Nillegoda; Zhen-Qiang Pan; Lan Huang
Journal:  J Proteome Res       Date:  2008-02-05       Impact factor: 4.466

10.  Changes in the ratio of free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes.

Authors:  Roland Hjerpe; Yann Thomas; Jesse Chen; Aleksandra Zemla; Siobhan Curran; Natalia Shpiro; Lawrence R Dick; Thimo Kurz
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.